With End Of Mandatory Retirement, U.S. Schools Face New Challenges

As change in law allows science faculty to keep working after age 70, academia must rethink its personnel policies. The end of mandatory retirement for faculty at United States colleges and universities--a policy change that became effective on January 1 of this year--is placing a new burden on the schools as well as individual faculty members. While the end of the longstanding policy has not brought about--as some administrators

Written byBilly Goodman
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


As change in law allows science faculty to keep working after age 70, academia must rethink its personnel policies.
The end of mandatory retirement for faculty at United States colleges and universities--a policy change that became effective on January 1 of this year--is placing a new burden on the schools as well as individual faculty members.

While the end of the longstanding policy has not brought about--as some administrators had feared--a deluge of complaints from young job candidates concerned about a dearth of future job openings, it is causing schools to take a hard look at their retirement incentive plans. At the same time, professors are now finding that they have to make independent decisions about when to stop working.

When Congress passed the 1986 amendments to the Age Discrimination in Employment Act (ADEA) of 1967, prohibiting mandatory retirement on the basis of age for most workers, it included several ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies